NEW YORK, Dec. 10, 2025 — As the World Well being Group warns that synthetic intelligence in healthcare could also be advancing sooner than security requirements can sustain with, a physician-CEO says the dialog is lacking a crucial level: clinically constructed and clinically ruled AI might now be one in every of the strongest life-saving instruments drugs has.
“The WHO is completely proper to spotlight the dangers that include the fast rise of AI in healthcare,” stated Dr. Essam Hamza, CEO of Rocket Physician AI Inc. “Too many methods rely on opaque algorithms and the chance of hallucinations, with out the authorized or scientific safeguards sufferers and well being staff deserve. At Rocket Physician AI, we’ve taken a basically completely different method.”
Rocket Physician AI is positioning its physician-built International Library of Drugs (GLM) and suite of AI-driven options as the counterpoint to opaque, hallucination-prone AI methods presently prompting world concern. As demand surges for reliable scientific instruments that scale back administrative load and strengthen accuracy in diagnoses, the firm believes its methodology, constructed over greater than a decade by lots of of clinicians, is the mannequin the trade wants.
“We use giant language fashions solely as a presentation layer — by no means as the supply of scientific judgment,” Dr. Hamza stated. “The scientific pathways, differential diagnoses and suggestions generated inside GLM are grounded in vetted, evidence-based medical information.
“This design ensures that AI is used to help, not substitute, healthcare professionals — strengthening security, enhancing decision-making and finally delivering higher outcomes for sufferers,” he continued. “Innovation in healthcare should transfer quick, but it surely should additionally transfer safely. Our dedication is to do each.”
Rocket Physician AI Inc. delivers physician-built, AI-powered options designed to make high-quality healthcare accessible all through the complete affected person journey. A cornerstone of the firm’s proprietary know-how is the International Library of Drugs (GLM), a clinically validated choice help system developed with enter from lots of of physicians worldwide.
Alongside the GLM is Rocket Physician Inc. and its AI-powered digital well being platform and market that has empowered over 300 MDs to ship greater than 700,000 affected person visits. By lowering administrative burdens and restoring autonomy to clinicians, Rocket Physician AI expands affected person entry whereas enhancing diagnostic consistency and supporting underserved communities in Canada and the United States.
Dr. Essam Hamza is a doctor, entrepreneur, know-how innovator, and CEO and Director of Rocket Physician AI Inc. with greater than twenty years of expertise advancing digital healthcare options. He earned his Physician of Drugs from the College of Alberta.
Dr. Hamza based HealthVue Ventures Ltd. in 2005, constructing a community of superior medical clinics that served over 100,000 sufferers. In 2018, he based CloudMD, a pioneer in digital healthcare know-how, and served as CEO and Director till 2022, guiding its progress right into a publicly traded firm on the TSX Enterprise Trade with income rising from underneath $4 million to over $100 million.
Dr. Hamza has additionally held management and advisory roles throughout the healthcare and biotechnology sectors, together with Unbiased Director at a lot of publicly traded corporations. With intensive capital markets expertise, he has efficiently scaled and financed a number of ventures at the intersection of medication and innovation.
Disclaimer: This article is sourced from external platforms. OverBeta has not independently verified the information. Readers are advised to verify details before relying on them.
